HOUSTON, TX / ACCESS Newswire / July 18, 2025 /CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a ...

Generation Bio Co. (Nasdaq: GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases, today announced that it will implement a 1-for-10 ...

West Pharmaceutical Services ( ($WST) ) has provided an update. On July 21, 2025, West Pharmaceutical Services announced the appointment of Robert ...

Generation Bio Co. (Nasdaq: GBIO), a biotechnology company working to change what's possible for people living with T cell-driven autoimmune diseases ...

HOUSTON, TX / ACCESS Newswire / July 18, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for pr ...

CNS Pharmaceuticals (NASDAQ: CNSP) , a biopharma company focused on treating brain and CNS cancers, will implement a 1-for-12 reverse stock split eff ...

BrainStorm Cell Therapeutics Inc. shares crashed 42.74% to $0.67 in after-hours trading on Friday after the company announced ...

FOXO Technologies Inc. (NYSE American: FOXO) ('FOXO” or the 'Company”), today announced that its Board of Directors has approved a 1 for 1.99 reverse stock split of the Company’s Class A common stock, ...

SHELTON, CT / ACCESS Newswire / July 21, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.: NNVC ) (the ...

NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the “Company”), and a clinical stage, leading global ...

BP (BP.), Ryanair (IE:RYA), Rightmove (RMV), profit warnings, Wise (WISE), Central Asia Metals (CAML), Oxford Nanopore (ONT), ...

Uncover the truth in this Jeff Brown Project Colossus review 2025. See if Near Future Report’s AI prediction is worth your time and money.